Galantamine: Research, Dosing, and Where to Buy in 2026

What is Galantamine?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Galantamine Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

Where to Buy Galantamine in 2026

Side Effects and Safety

What Experts Say

1 expert across our source library discuss Galantamine. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.

1. Dean · Designing Steroid Cycles For Enhanced Games Athletes:...Watch @ 1:00:22 ↗

   “pharmaceuticals for say Parkinson's like donepezil, galantamine, galantamine.”

User Reviews

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Galantamine. Each line links to the original source.

• "We used a fixed-effect model for meta-analytic synthesis, and presented results as Peto odds ratios (OR) or weighted mean differences (MD) with 95% confidence intervals." · Lim A et al, 2024 PubMed
• "The average age of participants was 74 years, and 37% were male." · Lim A et al, 2024 PubMed
• "Galantamine may improve global function at six months, as assessed with the Clinician's Interview-Based Impression of Change plus Caregiver Input (CIBIC-plus) (OR 1.58, 95% CI 1.36 to 1.84; 6 studies, 3002 participants; low-certainty evidence)." · Lim A et al, 2024 PubMed
• "Galantamine reduced death rates at six months: 1.3% of participants in the galantamine groups had died compared to 2.3% in the placebo groups (OR 0.56, 95% CI 0.33 to 0.96; 6 studies, 3493 participants; high-certainty evidence)." · Lim A et al, 2024 PubMed
• "Galantamine may not reduce death rates at 24 months compared to placebo (0.5% versus 0.1%) (OR 5.03, 95% CI 0.87 to 29.10; 2 studies, 2057 participants; low-certainty evidence)." · Lim A et al, 2024 PubMed
• "Statistically significant benefits favouring galantamine over placebo in assessments of cognition (ADAS-cog, MD -1.50, 95% CI -2.39 to -0.61, P = 0.0009), and favouring placebo compared with galantamine for behaviour (NPI, MD 1.80, 95% CI0.29 to 3.31, P = 0.02) are recorded." · Birks J et al, 2006 PubMed
• "Significantly higher numbers of patients dropped out from the group treated with galantamine compared with the placebo group (50/396 galantamine, 25/390 placebo OR 2.11, 95% CL 1.28 to 3.49, P = 0.004)." · Birks J et al, 2006 PubMed
• "The pooled odds ratios (95%CI) or the average differences (95%CI) were estimated." · Olin J et al, 2001 PubMed
• "For global ratings, trials of 3 months duration with doses of 24-32mg/d (Odds Ratio (OR) 2.2; 95%CI 1.4 to 3.7) and 36mg/d (OR 3.3; 95%CI 1.2 to 9.3) were statistically significant in favour of treatment." · Olin J et al, 2001 PubMed
• "For trials of 6 months duration (5-months to 29 weeks), only doses of 8mg/d failed to be statistically significant (24mg: OR 2.0; 95%CI 1.5 to2.5; 32mg: OR 1.9; 95%CI 1.4 to 2.5)." · Olin J et al, 2001 PubMed

Research and Studies

8 PubMed-indexed papers reference Galantamine. Top 8 shown.

Legal Status

Frequently Asked Questions